全球醫療食品增長機會

在全球醫療食品市場，相信醫藥製造商與醫療食品製造商之間的合作將增加增長機會。

按成分來看，蛋白質成分行業將在 2021 年佔據大部分份額，達到 64.0%，因為它在傷病康復方面發揮著重要作用。此外，由於醫生意識的提高和患者的醫療依從性提高，北美和歐洲將在 2021 年佔食品配料和成品的大部分份額。支持這些地區市場增長的因素是老年人口的增長、慢性病的流行以及政策制定者對營養不良管理的日益關注。

在本報告中，我們調查了全球醫療食品市場、市場背景、對市場的各種影響因素分析、法律法規和報銷環境、按成分和用途劃分的醫療食品的重要性、收益和銷售趨勢。它包括預測、分部和地區細分以及增長機會分析。

內容

戰略要務

• 為什麼增長越來越難
• 戰略要務 8(TM)
• 三大戰略要務的行業影響
• 推動增長管道引擎 (TM) 的增長機會

增長機會分析

• 分析範圍
• 醫療食品的定義
• 營養補充劑、醫療食品和藥品之間的區別
• 分類
• 定義：按成分
• 定義：按管理類型/模式
• 定義：按用途
• 主要公司
• 價值鏈
• 驅動程序
• 增長抑制
• 預測假設
• COVID-19：對醫療食品市場的影響
• COVID-19：觸發調查
• 受 COVID-19 影響的市場趨勢
• 監管狀況
• 監管狀態：北美
• 監管狀態：歐洲
• 監管格局：亞太地區
• 保險範圍和報銷方案

增長機會分析：醫療膳食成分

• 成長指數
• 成分在患者康復中的作用：蛋白質成分
• 成分在患者康復中的作用：營養脂質
• 成分在患者康復中的作用：益生元
• 成分在患者康復中的作用：維生素和礦物質
• 成分趨勢
• 收入預測
• 利潤預測：按組件分類
• 利潤預測分析：按組件
• 收入預測：按地區
• 收入預測分析：按地區
• 競爭環境
• 競爭對手產品矩陣
• 產品發布：醫用食品配料

增長機會分析：完成醫療飲食

• 成長指數
• 處方藥飲食示例
• 非處方藥用食品示例
• 醫學飲食的作用：營養不良
• 醫療食品的作用：代謝健康
• 醫療飲食的作用：消化系統健康
• 醫學飲食的作用：重症監護和創傷
• 醫學飲食的作用：肌肉骨骼健康
• 醫療飲食的作用：認知和中樞神經系統健康
• 醫療飲食的作用：糖尿病健康
• 醫療飲食的作用：心血管健康
• 收入預測
• 收入預測分析
• 收入預測：按類型
• 收入預測分析：按類型
• 收入預測：按管理模式
• 收入預測分析：按管理模式
• 收入預測：按地區
• 收入預測分析：按地區
• 收入率/市場滲透率：按應用
• 競爭環境
• 收入分成
• 近期收購
• 近期產品發布

增長機會領域

• 增長機會：醫藥製造商與醫療食品製造商之間的合作
• 增長機會：促銷活動和廣泛的報銷範圍
• 增長機會：醫療食品應用特定成分的設計研究更加關注
• 增長機會：功能材料的創新

下一步

Collaborative Efforts Between Drug Manufacturers and Medical Food Manufacturers to Boost Growth Opportunities for Medical Food

The US FDA defines medical food as "a food, which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation." Medical food is interpreted as 'food for special medical purposes (FSMPs)' in several countries, including Europe, India, China, and Australia and New Zealand. In Japan, medical food is interpreted as 'food for sick'. In Canada, medical food is governed by food for special dietary use (FSDU) and infant food regulations.

Globally, the regulatory landscape for medical food is not clearly defined, even in developed economies. As medical food is not intended to prevent or treat diseases, it is not subject to the same regulatory requirements as pharmaceutical drugs.

This Frost & Sullivan study aims to understand the role of medical food in patients' recovery. It provides qualitative and quantitative analyses of medical food ingredients and finished product medical food.

By ingredient, the medical food market is divided into vitamins and minerals; protein ingredients (animal and plant); nutritional lipids; prebiotics; and others (amino acids and probiotics). Of these, protein ingredients held the majority share of 64.0% (2021) in the total medical food ingredients market due to the important role they play in trauma and illness recovery.

Geographically, the study covers North America, Europe, Asia-Pacitfic, and Latin America and the Middle East and Africa (LAMEA). North America and Europe accounted for most of the market share for both medical food ingredients and finished product medical food in 2021 due to the rising physician awareness and the increasing medical adherence by patients. Factors supporting market growth in these regions are the expanding geriatric population, the prevalence of chronic diseases, and policymakers' growing emphasis on malnutrition management.

The impact of the COVID-19 pandemic is taken into account in the analysis. The pandemic induced both positive and negative changes in the medical food market. Supply chain disruptions due to the shutting down of processing facilities and other lockdown measures affected the sale of ingredients and finished medical food. However, the negaitve effects were reduced to some extent due to the growing consumer awareness and research highlighting the benefits of medical food in patients' recovery.

Key Features:

• By finished product, the medical food market is segmented by type, mode of administration, and application.

• By type, the medical food market is fragmented into prescription and nonprescription food. Prescription medical food dominated the medical food market with a 60.0% share in 2021 due to strong demand from developed economies for use in fatal health conditions such as oncology health, critical care and trauma, cardiovascular health, diabetes health, and cognitive health. Key market participants, such as Abbott, Nestle Health Science, and Nutricia, offer vast product portfolios of prescription medical food to meet the growing demand.

• By mode of administration, the medical food market is categorized into oral (food or supplement format) and enteral tube feeding. The oral mode accounted for the larger market share of 75.0% in 2021. Preference for orally administered products, ease of availability without prescriptions, and supportive initiatives are key factors driving demand for orally administered medical food.

• By application, the medical food market is segmented into malnutrition (including oncology health, immune health, and general malnutrition); metabolic health; digestive health; critical care and trauma; diabetes health; cardiovascular health; musculoskeletal health; and cognitive and central nervous system (CNS) health. Malnutrition, metabolic disorders, digestive disorders, and critical care and trauma are the top target diseases for medical food. Brain and cognitive health remains a small segment; nevertheless, it is one of the fastest-growing application areas for medical food.

Table of Contents

Strategic Imperatives

• Why is it Increasingly Difficult To Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Medical Food Industry
• Growth Opportunities Fuel The Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of Analysis
• Medical Food-Definition
• Differences between Dietary Supplements, Medical Food, and Pharmaceutical Drugs
• Segmentation
• Segmentation (continued)
• Definition by Ingredient Type
• Definition by Type and Mode of Administration
• Definition by Application
• Key Competitors
• Value Chain
• Growth Drivers
• Growth Restraints
• Forecast Assumptions
• Forecast Assumptions (continued)
• Impact of the COVID-19 Pandemic on the Medical Food Market
• COVID-19-Induced Research
• COVID-19-Induced Market Trends
• Regulatory Landscape
• Regulatory Landscape-North America
• Regulatory Landscape-Europe
• Regulatory Landscape-Asia-Pacific
• Regulatory Landscape-Asia-Pacific (continued)
• Insurance Coverage and Reimbursement Scenario
• Insurance Coverage and Reimbursement Scenario (continued)

Growth Opportunity Analysis-Medical Food Ingredients

• Growth Metrics
• Role of Ingredients in Patient Recovery-Protein Ingredients
• Role of Ingredients in Patient Recovery-Nutritional Lipids
• Role of Ingredients in Patient Recovery-Nutritional Lipids (continued)
• Role of Ingredients in Patient Recovery-Prebiotics
• Role of Ingredients in Patient Recovery-Vitamins and Minerals
• Role of Ingredients in Patient Recovery-Vitamins and Minerals (continued)
• Role of Ingredients in Patient Recovery-Vitamins and Minerals (continued)
• Ingredient Trends
• Ingredient Trends (continued)
• Ingredient Trends (continued)
• Revenue Forecast
• Revenue Forecast by Ingredient
• Revenue Forecast Analysis by Ingredients
• Revenue Forecast Analysis by Ingredients (continued)
• Revenue Forecast Analysis by Ingredients (continued)
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region
• Revenue Forecast Analysis by Region (continued)
• Competitive Environment
• Competitive Product Matrix
• Product Launches-Medical Food Ingredients: 2021 and 2022
• Product Launches-Medical Food Ingredients: 2021
• Product Launches-Medical Food Ingredients: 2020 and 2022
• Product Launches-Medical Food Ingredients: 2019 and 2020

Growth Opportunity Analysis-Finished Product Medical Food

• Growth Metrics
• Prescription Medical Food-Examples
• Nonprescription Medical Food-Examples
• Role of Medical Food in Malnutrition Condition
• Role of Medical Food in Malnutrition Condition (continued)
• Role of Medical Food in Malnutrition Condition (continued)
• Role of Medical Food in Metabolic Health
• Role of Medical Food in Metabolic Health (continued)
• Role of Medical Food in Digestive Health
• Role of Medical Food in Critical Care and Trauma
• Role of Medical Food in Musculoskeletal Health
• Role of Medical Food in Cognitive and CNS Health
• Role of Medical Food in Diabetes Health
• Role of Medical Food in Cardiovascular Health
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast Analysis (continued)
• Revenue Forecast by Type
• Revenue Forecast Analysis by Type
• Revenue Forecast by Mode of Administration
• Revenue Forecast Analysis by Mode of Administration
• Revenue Forecast Analysis by Mode of Administration (continued)
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region
• Revenue Forecast Analysis by Region (continued)
• Revenue Forecast Analysis by Region (continued)
• Revenue Forecast Analysis by Region (continued)
• Revenue Forecast Analysis by Region (continued)
• Percent Revenue by Application and Market Penetration
• Competitive Environment
• Revenue Share
• Recent Acquisitions-2019-2022
• Recent Product Launches-2019, 2020, and 2021

Growth Opportunity Universe

• Growth Opportunity 1: Collaborative Efforts between Drug Manufacturers and Medical Food Manufacturers
• Growth Opportunity 1: Collaborative Efforts between Drug Manufacturers and Medical Food Manufacturers (continued)
• Growth Opportunity 2: Promotional Activities and Wide Reimbursement Coverage
• Growth Opportunity 2: Promotional Activities and Wide Reimbursement Coverage (continued)
• Growth Opportunity 3: Increased Research Focus on Designing Specific Ingredients for Medical Food Applications
• Growth Opportunity 3: Increased Research Focus on Designing Specific Ingredients for Medical Food Applications (continued)
• Growth Opportunity 4: Innovation in Functional Ingredients
• Growth Opportunity 4: Innovation in Functional Ingredients (continued)

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• List of Exhibits (continued)
• Legal Disclaimer